Attached files
| file | filename |
|---|---|
| EX-32.1 - EX-32.1 - ARENA PHARMACEUTICALS INC | arna-ex321_10.htm |
| EX-31.2 - EX-31.2 - ARENA PHARMACEUTICALS INC | arna-ex312_12.htm |
| EX-31.1 - EX-31.1 - ARENA PHARMACEUTICALS INC | arna-ex311_11.htm |
| EX-23.1 - EX-23.1 - ARENA PHARMACEUTICALS INC | arna-ex231_6.htm |
| EX-10.48 - EX-10.48 - ARENA PHARMACEUTICALS INC | arna-ex1048_1274.htm |
| EX-10.46 - EX-10.46 - ARENA PHARMACEUTICALS INC | arna-ex1046_1273.htm |
| EX-10.44 - EX-10.44 - ARENA PHARMACEUTICALS INC | arna-ex1044_1272.htm |
| 10-K - 10-K - ARENA PHARMACEUTICALS INC | arna-10k_20171231.htm |
Exhibit 21.1
Subsidiaries of Arena Pharmaceuticals, Inc.
As of December 31, 2017
125 Royalty Inc., a Delaware corporation
356 Royalty Inc., a Delaware corporation
Arena Pharmaceuticals Development GmbH, a limited liability company organized under the laws of Switzerland and having its domicile in Zug
Arena Pharmaceuticals GmbH, a limited liability company organized under the laws of Switzerland and having its domicile in Zofingen
API Development LTD, a company incorporated in the Cayman Islands with limited liability